NasdaqCM - Nasdaq Real Time Price USD

Exicure, Inc. (XCUR)

11.13
-0.73
(-6.16%)
As of 11:50:40 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
500
500
0
28,826
-483
Operating Expense
5,449
5,449
13,138
30,657
62,066
Operating Income
-4,949
-4,949
-13,138
-1,831
-62,549
Net Non Operating Interest Income Expense
-10
-10
32
-580
-1,550
Other Income Expense
-4,734
-4,734
-3,808
38
-3
Pretax Income
-9,693
-9,693
-16,914
-2,373
-64,102
Tax Provision
8
8
0
209
0
Net Income Common Stockholders
-9,701
-9,701
-16,914
-2,582
-64,102
Diluted NI Available to Com Stockholders
-9,701
-9,701
-16,914
-2,582
-64,102
Basic EPS
-2.02
-4.75
-10.55
-2.80
-108.50
Diluted EPS
-2.02
-4.75
-10.55
-2.80
-108.50
Basic Average Shares
1,824.33
2,043.28
1,602.79
923.89
590.78
Diluted Average Shares
1,824.33
2,043.28
1,602.79
923.89
590.78
Total Operating Income as Reported
-12,232
-12,232
-14,996
-1,831
-62,549
Total Expenses
5,449
5,449
13,138
30,657
62,066
Net Income from Continuing & Discontinued Operation
-9,701
-9,701
-16,914
-2,582
-64,102
Normalized Income
-3,951.38
-3,951.38
-13,108
-2,643.62
-64,110
Interest Income
8
8
32
15
141
Interest Expense
18
18
0
595
1,691
Net Interest Income
-10
-10
32
-580
-1,550
EBIT
-9,675
-9,675
-16,914
-1,778
-62,411
EBITDA
-8,851
-8,851
-15,539
78
-60,632
Reconciled Depreciation
824
824
1,375
1,856
1,779
Net Income from Continuing Operation Net Minority Interest
-9,701
-9,701
-16,914
-2,582
-64,102
Total Unusual Items Excluding Goodwill
-7,278
-7,278
-3,806
78
8
Total Unusual Items
-7,278
-7,278
-3,806
78
8
Normalized EBITDA
-1,573
-1,573
-11,733
0
-60,640
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,528.38
-1,528.38
0
16.38
0
12/31/2021 - 5/22/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VINC Vincerx Pharma, Inc.
0.0501
-8.91%
 
REVB Revelation Biosciences, Inc.
3.1441
-3.56%
 
MOLN Molecular Partners AG
3.9500
-8.99%
 
MNPR Monopar Therapeutics Inc.
35.26
+0.46%
 
TRAW Traws Pharma, Inc.
1.1600
-16.55%
 
GNTA Genenta Science S.p.A.
4.1650
+3.87%
 
KZIA Kazia Therapeutics Limited
3.5800
+1.70%
 
PRTG Portage Biotech Inc.
7.64
+0.39%
 
VTYX Ventyx Biosciences, Inc.
1.2100
0.00%
 
ORGS Orgenesis Inc.
2.0000
+2.56%